Clover Health officer proposes $18.2K share sale

The reported history also lists five sales in the prior three months; 4,066 restricted stock units were acquired from the issuer on October 15, 2026.

Rhea-AI Filing Summary

Clover Health Investments, Corp. officer Jamie Reynoso reported a proposed sale of 4,066 common shares, with an aggregate market value of $18,215.68, through Morgan Stanley Smith Barney LLC for an approximate sale date of October 19, 2026. His sales history for the prior three months lists 18,273 shares on October 15, 2,006 on October 7, 8,750 on October 5, 1,921 on September 17 and 9,273 on September 15, 2026.

Key Figures

Proposed sale: 4,066 common shares Aggregate market value: $18,215.68 Restricted stock units acquired: 4,066 restricted stock units +5 more

8 metrics

Proposed sale 4,066 common shares Approximate sale date October 19, 2026

Aggregate market value $18,215.68 Proposed sale

Restricted stock units acquired 4,066 restricted stock units October 15, 2026

Sale on October 15, 2026 18,273 shares; $85,543.71 Reported sale during the prior three months

Sale on October 7, 2026 2,006 shares; $9,295.20 Identified as a 10b5-1 sale

Sale on October 5, 2026 8,750 shares; $38,675.00 Reported sale during the prior three months

Sale on September 17, 2026 1,921 shares; $8,759.76 Identified as a 10b5-1 sale

Sale on September 15, 2026 9,273 shares; $44,324.94 Reported sale during the prior three months

Key Terms

Rule 144, 10b5-1 Sales, Restricted Stock Units

3 terms

Rule 144 regulatory

"the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for Jamie Reynoso"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Restricted Stock Units financial

"Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLOV shares is Jamie Reynoso proposing to sell?

Jamie Reynoso's proposed sale is 4,066 common shares, with an aggregate market value of $18,215.68 and an approximate sale date of October 19, 2026. Morgan Stanley Smith Barney LLC is listed as the broker.

What recent sales did Jamie Reynoso report for CLOV?

The reported sales were 18,273 shares for $85,543.71 on October 15, 2026; 2,006 for $9,295.20 on October 7; 8,750 for $38,675.00 on October 5; 1,921 for $8,759.76 on September 17; and 9,273 for $44,324.94 on September 15. The October 7 and September 17 entries are identified as 10b5-1 sales.

Were CLOV restricted stock units acquired before the proposed sale?

The securities information lists 4,066 restricted stock units acquired from the issuer on October 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 04:27 PM EDT Accepted by SEC EDGAR 10/19/2026 - 04:27 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	JAMIE REYNOSO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4066	18215.68	435441337	10/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/15/2026	Restricted Stock Units	Issuer			4066	10/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	10/15/2026	18273	85543.71
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	10/07/2026	2006	9295.20
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	10/05/2026	8750	38675.00
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	09/17/2026	1921	8759.76
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	09/15/2026	9273	44324.94

144: Remarks and Signature

Remarks
Date of Notice	10/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jamie Reynoso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)